TECHNOLOGY TRANSFER
Georgia State University’s Office of Technology Licensing & Commercialization works to ensure that great ideas find their way out of the lab and into the hands of the people who need them.
INLIGHTA BIOSCIENCES
Jenny Yang, Founder & President
Regents’ Professor of Chemistry
YEAR FOUNDED
2012
DEVELOPMENT STATUS
Preclinical
FUNDING SUPPORT
National Cancer Institute
Georgia Research Alliance
A Novel Method of Early Cancer Detection
InLighta Biosciences distributes cutting-edge diagnostic tools to help detect disease, including cancers and liver disease. InLighta’s MRI contrast agents facilitate improved, non-invasive patient imaging, allowing for earlier clinical diagnoses, continued monitoring of progression and recurrence of diseases such as cancer and fibrosis, and evaluation of drug delivery and therapeutic treatment.
Their first anticipated commercial product, MRI contrast agent ProCA32.Collagen1, which binds to collagen and can detect early liver disease and very small tumors, has been reviewed by the U.S. Food and Drug Administration and may be granted fast-track status in the first step toward clinical trials with breakthrough designation.
—Jenny Yang
READ MORE
TECHNOLOGY TRANSFER
Georgia State University’s Office of Technology Licensing & Commercialization works to ensure that great ideas find their way out of the lab and into the hands of the people who need them.